Sign in

CIK 0002044950

Bambusa Therapeutics, Inc.

Sign in to watch
Ticker
BBTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
992083913
Phone
(617) 848-6188
Business address
22 BOSTON WHARF ROAD, FLOOR 7, BOSTON, MA
  1. SCHEDULE 13D Stake Beneficial Ownership Report
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Open-market buy Director bought 2,953,820 shares at an average $15.79 ($46,639,957)
  4. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  5. 4 Open-market buy 10% owner bought 375,000 shares at $16.00 ($6,000,000)
  6. 4 Open-market buy Director bought 375,000 shares at $16.00 ($6,000,000)
  7. 4 Conversion See remarks acquired 163,596 shares (conversion)
  8. 4 Derivatives Options or other derivatives
  9. 424B4 Offering Prospectus
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. EFFECT Other Notice of Effectiveness
  12. S-1MEF Other S-1MEF
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 30 filings